Literature DB >> 19604524

Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects.

Umesh Masharani1, Ira D Goldfine, Jack F Youngren.   

Abstract

Individuals with obesity frequently have an atherogenic lipid profile. It has been proposed that the insulin resistance observed in these individuals is involved in the development of these lipid abnormalities. However, most studies that have examined the relationship between insulin resistance and lipid abnormalities have included subjects who are either obese and/or glucose intolerant, 2 factors that may affect lipid levels independent of insulin resistance. We have therefore examined the impact of insulin resistance on plasma lipids in a healthy, lean (average body mass index <24 kg/m(2)), nondiabetic population (N = 104). In our subjects, we observed a wide range of values for insulin sensitivity index (ISI) as calculated by the formula of Matsuda and DeFronzo. Lipid values ranged considerably in this population, but incidence of hypertriglyceridemia and hypercholesterolemia was low in the absence of obesity. We first examined the relationship between ISI and total and regional adipose stores as assessed by dual-energy x-ray absorptiometry. In men, we observed higher values for indices of total and central adipose stores that were significantly associated with decreased insulin sensitivity. In contrast, in women, ISI values were not associated with any variables related to either total or regional adiposity. In men, ISI was also significantly associated with higher triglycerides levels (P < .01) when adjusted for age and percentage of truncal fat. In women however, there was no significant association between ISI and triglycerides (P = .14). Instead, in women, total fat and truncal fat were independent predictors of several lipid levels. These results both highlight sex differences in the associations between insulin resistance, regional adipose stores, and lipids values and emphasize the importance of adipose stores on the development of an individual's lipid profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604524      PMCID: PMC2763945          DOI: 10.1016/j.metabol.2009.05.012

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  31 in total

1.  Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin.

Authors:  E S Tai; T N Lau; S C Ho; A C Fok; C E Tan
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

Review 2.  Regional adiposity and insulin resistance.

Authors:  Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

3.  Relationship between lipoprotein levels and in vivo insulin action in normal young white men.

Authors:  A Garg; J H Helderman; M Koffler; R Ayuso; J Rosenstock; P Raskin
Journal:  Metabolism       Date:  1988-10       Impact factor: 8.694

Review 4.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

5.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

6.  Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.

Authors:  M Laakso; K Pyörälä; E Voutilainen; J Marniemi
Journal:  Am J Epidemiol       Date:  1987-04       Impact factor: 4.897

7.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

8.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

9.  Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population.

Authors:  W G Abbott; S Lillioja; A A Young; J K Zawadzki; H Yki-Järvinen; L Christin; B V Howard
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.

Authors:  Tracey McLaughlin; Gregory Allison; Fahim Abbasi; Cindy Lamendola; Gerald Reaven
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

View more
  9 in total

1.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

2.  Inflammation and biochemical features of bariatric candidates: does gender matter?

Authors:  Alvaro A C Morais; Joel Faintuch; Ana A D Leal; Joao A B Noe; Diandria M Bertollo; Rafael C Morais; Daniele Cabrini
Journal:  Obes Surg       Date:  2010-02-02       Impact factor: 4.129

3.  Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.

Authors:  Umesh B Masharani; Betty A Maddux; Xiaojuan Li; Giorgos K Sakkas; Kathleen Mulligan; Morris Schambelan; Ira D Goldfine; Jack F Youngren
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

4.  Obesity and obesity-related comorbidities in a Canadian First Nation population.

Authors:  Sharon G Bruce; Natalie D Riediger; James M Zacharias; T Kue Young
Journal:  Prev Chronic Dis       Date:  2010-12-15       Impact factor: 2.830

5.  The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance in Chinese Nonobese Women.

Authors:  Jiyun He; Sen He; Kai Liu; Yong Wang; Di Shi; Xiaoping Chen
Journal:  Int J Endocrinol       Date:  2014-07-21       Impact factor: 3.257

6.  Lifestyle-Intervention-Induced Reduction of Abdominal Fat Is Reflected by a Decreased Circulating Glycerol Level and an Increased HDL Diameter.

Authors:  Marian Beekman; Bianca A M Schutte; Erik B van den Akker; Raymond Noordam; Petra Dibbets-Schneider; Lioe-Fee de Geus-Oei; Joris Deelen; Ondine van de Rest; Diana van Heemst; Edith J M Feskens; P Eline Slagboom
Journal:  Mol Nutr Food Res       Date:  2020-04-23       Impact factor: 5.914

7.  Causal relationships between obesity and the leading causes of death in women and men.

Authors:  Jenny C Censin; Sanne A E Peters; Jonas Bovijn; Teresa Ferreira; Sara L Pulit; Reedik Mägi; Anubha Mahajan; Michael V Holmes; Cecilia M Lindgren
Journal:  PLoS Genet       Date:  2019-10-24       Impact factor: 5.917

8.  Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort.

Authors:  Therese Tillin; Alun D Hughes; Ian F Godsland; Peter Whincup; Nita G Forouhi; Paul Welsh; Naveed Sattar; Paul M McKeigue; Nish Chaturvedi
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

9.  Which insulin resistance-based definition of metabolic syndrome has superior diagnostic value in detection of poor health-related quality of life? Cross-sectional findings from Tehran Lipid and Glucose Study.

Authors:  Tina Deihim; Parisa Amiri; Reza Taherian; Maryam Tohidi; Asghar Ghasemi; Leila Cheraghi; Fereidoun Azizi
Journal:  Health Qual Life Outcomes       Date:  2015-12-09       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.